Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis

Table 1 Patient characteristics at baseline, n (%)

Characteristic	All (n = 255)
Age (years), mean ± SD	40.2 ± 8.9
Sex
Male	195 (76.5)
Female	60 (23.5)
BMI (kg/m2), mean ± SD	26.7 ± 3.9
History of hypertension	42 (16.5)
History of diabetes	60 (23.5)
Pleural effusion	129 (50.6)
Peritoneal effusion	78 (30.6)
Localized complications	183 (71.8)
APFC	62 (24.3)
ANC	93 (36.5)
PPC	17 (6.7)
WON	3 (1.2)
IPN	8 (3.1)
Systemic complications	135 (52.9)
Respiratory failure	53 (20.8)
Renal failure	39 (15.3)
Circulatory failure	16 (6.3)
SIRS	123 (48.2)
Sepsis	17 (6.7)
ACS	22 (8.6)
ARDS	16 (6.3)
MODS	32 (12.5)
Grades of severity
MAP	72 (28.2)
MSAP	126 (49.4)
SAP	57 (22.4)
ICU admission	54 (21.2)
Length of hospital stays (days), median (IQR)	10 (6, 14)
Total costs (thousand CNY), median (IQR)	19.7 (11.0, 37.8)
Mortality	2 (0.78)

IQR: Interquartile range; BMI: Body mass index; APFC: Acute peripancreatic fluid collection; ANC: Acute necrotic collection; PPC: Pancreatic pseudocyst; WON: Walled-off necrosis; IPN: Infected pancreatic necrosis; SIRS: Systemic inflammatory response syndrome; ACS: Abdominal compartment syndrome; ARDS: Acute respiratory distress syndrome; MODS: Multiple organ dysfunction syndrome; MAP: Mild acute pancreatitis; MSAP: Moderately severe acute pancreatitis; SAP: Severe acute pancreatitis; CNY: China yuan; ICU: Intensive care unit.